213 related articles for article (PubMed ID: 29357859)
1. Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx].
Bonassi S; Prinzi G; Lamonaca P; Russo P; Paximadas I; Rasoni G; Rossi R; Ruggi M; Malandrino S; Sánchez-Flores M; Valdiglesias V; Benassi B; Pacchierotti F; Villani P; Panatta M; Cordelli E
BMC Complement Altern Med; 2018 Jan; 18(1):22. PubMed ID: 29357859
[TBL] [Abstract][Full Text] [Related]
2. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
[TBL] [Abstract][Full Text] [Related]
3. VERIFICATION OF AUTHENTICITY OF
Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
[No Abstract] [Full Text] [Related]
4. Mechanistic evaluation of Ginkgo biloba leaf extract-induced genotoxicity in L5178Y cells.
Lin H; Guo X; Zhang S; Dial SL; Guo L; Manjanatha MG; Moore MM; Mei N
Toxicol Sci; 2014 Jun; 139(2):338-49. PubMed ID: 24595819
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba leaf extract: review of biological actions and clinical applications.
Yoshikawa T; Naito Y; Kondo M
Antioxid Redox Signal; 1999; 1(4):469-80. PubMed ID: 11233145
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity, genotoxicity and gene expression changes elicited by exposure of human hepatic cells to Ginkgo biloba leaf extract.
Grollino MG; Raschellà G; Cordelli E; Villani P; Pieraccioli M; Paximadas I; Malandrino S; Bonassi S; Pacchierotti F
Food Chem Toxicol; 2017 Nov; 109(Pt 1):486-496. PubMed ID: 28943387
[TBL] [Abstract][Full Text] [Related]
7. Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells.
Zhang Z; Chen S; Mei H; Xuan J; Guo X; Couch L; Dobrovolsky VN; Guo L; Mei N
Sci Rep; 2015 Sep; 5():14633. PubMed ID: 26419945
[TBL] [Abstract][Full Text] [Related]
8. EGb 761: ginkgo biloba extract, Ginkor.
Drugs R D; 2003; 4(3):188-93. PubMed ID: 12757407
[TBL] [Abstract][Full Text] [Related]
9. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
10. Human pregnane X receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides.
Lau AJ; Yang G; Rajaraman G; Baucom CC; Chang TK
J Pharmacol Exp Ther; 2010 Dec; 335(3):771-80. PubMed ID: 20739453
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
[TBL] [Abstract][Full Text] [Related]
12. Determination of ginkgolide A, B, and bilobalide in biloba L. extracts by microdialysis-HPLC.
Chiu HL; Lin HY; Yang TC
Anal Bioanal Chem; 2004 Jun; 379(3):445-8. PubMed ID: 15057504
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.
Vellas B; Coley N; Ousset PJ; Berrut G; Dartigues JF; Dubois B; Grandjean H; Pasquier F; Piette F; Robert P; Touchon J; Garnier P; Mathiex-Fortunet H; Andrieu S;
Lancet Neurol; 2012 Oct; 11(10):851-9. PubMed ID: 22959217
[TBL] [Abstract][Full Text] [Related]
14. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver.
Sasaki K; Hatta S; Wada K; Ueda N; Yoshimura T; Endo T; Sakata M; Tanaka T; Haga M
Life Sci; 2002 Feb; 70(14):1657-67. PubMed ID: 11991253
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].
Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A
Therapie; 1995; 50(2):137-44. PubMed ID: 7631288
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba extract for age-related macular degeneration.
Evans JR
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD001775. PubMed ID: 23440785
[TBL] [Abstract][Full Text] [Related]
17. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.
Chen F; Li L; Xu F; Sun Y; Du F; Ma X; Zhong C; Li X; Wang F; Zhang N; Li C
Br J Pharmacol; 2013 Sep; 170(2):440-57. PubMed ID: 23808355
[TBL] [Abstract][Full Text] [Related]
18. Moderate doses of commercial preparations of Ginkgo biloba do not alter markers of liver function but moderate alcohol intake does: A new approach to identify and quantify biomarkers of 'adverse effects' of dietary supplements.
Lieberman HR; Kellogg MD; Fulgoni VL; Agarwal S
Regul Toxicol Pharmacol; 2017 Mar; 84():45-53. PubMed ID: 28025058
[TBL] [Abstract][Full Text] [Related]
19. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
[TBL] [Abstract][Full Text] [Related]
20. Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports.
Mei N; Guo X; Ren Z; Kobayashi D; Wada K; Guo L
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2017 Jan; 35(1):1-28. PubMed ID: 28055331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
